Through this route, the development of local and systemic inflammation occurs involving the release of pro-inflammatory mediators such as IL-1β, among others contributing to neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases39–41. The gene discussed is IL1B; the disease is neurodegenerative disease.